| Business Summary | | Cyanotech
Corporation
is
engaged
in
the
development
and
commercialization
of
natural
products
derived
from
microalgae.
The
Company
produces
natural
products
from
microalgae
for
the
nutritional
supplement,
aquaculture
feed,
animal
nutrition
and
immunological
diagnostics
markets.
Cyanotech
has
been
producing
microalgae-based
"Spirulina"
products
for
the
vitamin
and
supplement
market.
Spirulina
Pacifica
is
a
strain
of
Spirulina
that
provides
a
vegetable-based,
highly
absorbable
source
of
natural
beta-carotene,
mixed
carotenoids,
B
vitamins,
gamma
linolenic
acid,
protein,
essential
amino
acids
and
other
phytonutrients.
NatuRose
is
the
brand
name
of
its
natural
astaxanthin
product
for
the
animal
nutrition
market,
which
the
Company
produces
from
the
microalgae,
Haematococcus.
In
March
1999,
the
Company
announced
the
development
of
BioAstin,
its
natural
astaxanthin
product
for
the
human
nutrition
market. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CYAN
develops
and
commercializes
products
from
microalgae
for
nutritional
supplement
and
immunological
diagnostics
markets.
For
the
three
months
ended
6/30/01,
revenues
increased
7%
to
$2.3
million.
Net
loss
applicable
to
Common
totaled
$413
thousand,
up
from
$61
thousand.
Revenues
reflect
increased
sales
of
packaged
consumer
products,
packaged
private
label
products
and
bulk
spirulina
products.
Higher
loss
reflects
increased
advertising
and
promotion
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Gerald Cysewski, Ph.D., 51 Chairman,
Pres and CEO | $103K | Ronald Scott, 45 Exec.
VP of Fin. and Admin., Sec., Treasurer | -- | Glenn Jensen, 41 VP
of Operations | -- | Kelly Moorhead, 44 VP
of Sales and Marketing | -- | Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|